Literature DB >> 12880942

Clinical impact of a 2-week psychotropic medication washout in unipolar depressed inpatients.

Michael F Grunebaum1, Maria A Oquendo, Ainsley K Burke, Steven P Ellis, Gonzalo Echavarria, Beth S Brodsky, Kevin M Malone, J John Mann.   

Abstract

BACKGROUND: Short-term discontinuation of psychiatric medications is required in many types of research studies. Yet there are few studies of the clinical impact of psychotropic discontinuation. We studied the impact of a short-term medication washout in unipolar depressed patients consecutively admitted to hospital for neuroimaging and cerebrospinal fluid (CSF) studies.
METHOD: Patients (n=51) with unipolar depression who were taking antidepressant or mood stabilizing medication at or within 1 week of admission, and who had not been responding satisfactorily, were assessed for severity of psychopathology within 1 week of hospital admission and 41 of the group were reassessed following an approximately 2-week medication washout.
RESULTS: On average, patients remained stable during the washout or improved on clinical measures. No serious adverse clinical changes were observed. LIMITATIONS: Potential sample bias, small sample size.
CONCLUSION: The results suggest that similar studies can be conducted without causing undue worsening of symptoms. The benefit of medication washout may be related to the fact that many of the patients had been responding poorly to the medication they were taking. There is a need for further research on the effects of medication washout, for example in outpatients or those who are responding well to treatment, but have intolerable side-effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880942     DOI: 10.1016/s0165-0327(02)00168-4

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  The Ethics of Clinical Trials Research in Severe Mood Disorders.

Authors:  Allison C Nugent; Franklin G Miller; Ioline D Henter; Carlos A Zarate
Journal:  Bioethics       Date:  2017-05-15       Impact factor: 1.898

2.  Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.

Authors:  Allison C Nugent; Nicolas D Iadarola; Frank G Miller; David A Luckenbaugh; Carlos A Zarate
Journal:  Lancet Psychiatry       Date:  2016-03-10       Impact factor: 27.083

3.  Polypharmacy or medication washout: an old tool revisited.

Authors:  Daniel A Hoffman; Mark Schiller; James M Greenblatt; Dan V Iosifescu
Journal:  Neuropsychiatr Dis Treat       Date:  2011-10-20       Impact factor: 2.570

Review 4.  Research risk for persons with psychiatric disorders: a decisional framework to meet the ethical challenge.

Authors:  Philip T Yanos; Barbara S Stanley; Carolyn S Greene
Journal:  Psychiatr Serv       Date:  2009-03       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.